Sandra Liliana Valderrama-beltrán - Infectious Diseases

Author Information

Sandra Liliana Valderrama-Beltrán is affiliated with the Division of Infectious Diseases, Department of Internal Medicine at the Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana in Bogotá, Colombia. Her work primarily focuses on infectious diseases, with a significant contribution to the understanding and management of infections in clinical settings.

Research Contributions

Sandra Liliana Valderrama-Beltrán has made substantial contributions to the field of infectious diseases, particularly in understanding and managing antimicrobial resistance and infections in hospital settings. Her research includes studying outbreaks, such as the Ralstonia pickettii bacteremia, and exploring the implications of antibiotic use during the COVID-19 pandemic in Latin America. She has also been involved in modeling analyses to understand the impact of therapeutics on SARS-CoV-2 transmission and disease burden, as well as investigating clinical outcomes related to carbapenem-resistant Klebsiella pneumoniae. Her work is instrumental in advancing knowledge on infectious disease prevention and treatment, especially in low-income and middle-income countries.

Aliases

Sandra Liliana Valderrama-Beltrán is known by various names including Sandra L Valderrama-Beltrán, Sandra Valderrama-Beltrán, Sandra Liliana Valderrama-Beltran, and Sandra Valderrama-Beltran.

Publication and Citation Metrics

Metric	Value
Total Papers	41
Citation Count	425
H-index	10

Publications:

Screening With Anal Cytology in Colombia: Initial Experience and Need for High-Resolution Anoscopy.

DOI: 10.1016/j.jss.2021.05.037

Year: 2021

805. Outbreak of Ralstonia pickettii Bacteremia Caused by Contaminated Hydromorphone in a Universitary Hospital in Bogota, Colombia

DOI: 10.1093/ofid/ofab466.1001

Year: 2021

Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America

DOI: 10.3390/antibiotics10030328

Year: 2021

Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.

DOI: 10.1093/cid/ciab837

Year: 2021

Understanding the Potential Role of Therapeutics in Preventing Deaths Due to COVID-19: A Modelling Analysis

DOI: 10.2139/ssrn.3817420

Year: 2021

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

DOI: 10.1016/s1473-3099(21)00399-6

Year: 2021

Anal cancer screening in low-income and middle-income countries.

DOI: 10.1016/S2468-1253(21)00180-1

Year: 2021

Methicillin-resistant Staphylococcus aureus nasal colonization in cardiovascular surgery patients at a university hospital in Bogotá, Colombia

DOI: 10.7705/BIOMEDICA.4791

Year: 2020

Persistence of Clonal Azole-Resistant Isolates of Candida albicans from a Patient with Chronic Mucocutaneous Candidiasis in Colombia

DOI: 10.4103/jgid.jgid_74_19

Year: 2020

In-house protocol and performance of MALDI-TOF MS in the early diagnosis of bloodstream infections in a fourth-level hospital in Colombia: jumping to full use of this technology.

DOI: 10.1016/j.ijid.2020.09.1469

Year: 2020

What are the Implications of Genomics for Treatment?

What Are the Limitations of Blood Tests?

What are the treatment options for Flaviviridae infections?

Can Yellow Fever be Prevented?

What Role Do ID Specialists Play in Public Health?

What are the Treatments for HSV?

What are Quarantine and Isolation?

What are Infectious Agents?

Why Are Cohort Studies Important?

Why Are Drug Targets Important in Infectious Diseases?

Partnered Content Networks

Relevant Topics